These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

660 related items for PubMed ID: 28373293

  • 1. Lipid metabolism and its implications for type 1 diabetes-associated cardiomyopathy.
    Ritchie RH, Zerenturk EJ, Prakoso D, Calkin AC.
    J Mol Endocrinol; 2017 May; 58(4):R225-R240. PubMed ID: 28373293
    [Abstract] [Full Text] [Related]

  • 2. Taking diabetes to heart--deregulation of myocardial lipid metabolism in diabetic cardiomyopathy.
    Bayeva M, Sawicki KT, Ardehali H.
    J Am Heart Assoc; 2013 Nov 25; 2(6):e000433. PubMed ID: 24275630
    [No Abstract] [Full Text] [Related]

  • 3. Role of changes in cardiac metabolism in development of diabetic cardiomyopathy.
    An D, Rodrigues B.
    Am J Physiol Heart Circ Physiol; 2006 Oct 25; 291(4):H1489-506. PubMed ID: 16751293
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Gene therapy targeting cardiac phosphoinositide 3-kinase (p110α) attenuates cardiac remodeling in type 2 diabetes.
    Prakoso D, De Blasio MJ, Tate M, Kiriazis H, Donner DG, Qian H, Nash D, Deo M, Weeks KL, Parry LJ, Gregorevic P, McMullen JR, Ritchie RH.
    Am J Physiol Heart Circ Physiol; 2020 Apr 01; 318(4):H840-H852. PubMed ID: 32142359
    [Abstract] [Full Text] [Related]

  • 11. TLR4 regulates cardiac lipid accumulation and diabetic heart disease in the nonobese diabetic mouse model of type 1 diabetes.
    Dong B, Qi D, Yang L, Huang Y, Xiao X, Tai N, Wen L, Wong FS.
    Am J Physiol Heart Circ Physiol; 2012 Sep 15; 303(6):H732-42. PubMed ID: 22842069
    [Abstract] [Full Text] [Related]

  • 12. FOXO1 contributes to diabetic cardiomyopathy via inducing imbalanced oxidative metabolism in type 1 diabetes.
    Yan D, Cai Y, Luo J, Liu J, Li X, Ying F, Xie X, Xu A, Ma X, Xia Z.
    J Cell Mol Med; 2020 Jul 15; 24(14):7850-7861. PubMed ID: 32450616
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Diabetic cardiomyopathy: recent evidence from mouse models of type 1 and type 2 diabetes.
    Severson DL.
    Can J Physiol Pharmacol; 2004 Oct 15; 82(10):813-23. PubMed ID: 15573141
    [Abstract] [Full Text] [Related]

  • 18. Mitochondrial dysfunction in diabetic cardiomyopathy.
    Duncan JG.
    Biochim Biophys Acta; 2011 Jul 15; 1813(7):1351-9. PubMed ID: 21256163
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. How exercise may amend metabolic disturbances in diabetic cardiomyopathy.
    Hafstad AD, Boardman N, Aasum E.
    Antioxid Redox Signal; 2015 Jun 10; 22(17):1587-605. PubMed ID: 25738326
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.